|4Apr 23, 1:40 PM ET

DOCHERTY JOHN MARTIN 4

4 · Lexaria Bioscience Corp. · Filed Apr 23, 2020

Insider Transaction Report

Form 4
Period: 2020-04-23
DOCHERTY JOHN MARTIN
DirectorPresident
Transactions
  • Award

    stock options

    2020-04-23+400,0001,250,000 total
    Exercise: $0.32From: 2020-04-23Exp: 2025-04-23common shares (400,000 underlying)
Holdings
  • common shares

    (indirect: Private Holding Company)
    1,622,250
  • stock options

    Exercise: $0.47From: 2020-02-07Exp: 2025-02-07common shares (550,000 underlying)
    850,000
  • stock options

    Exercise: $0.11From: 2016-04-15Exp: 2021-04-15common shares (300,000 underlying)
    300,000

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT